SPT Labtech strengthens executive team
SPT Labtech, a laboratory automation solutions company for the life sciences industry, has revealed a leadership transformation to further capitalise on its organic and acquisition-led growth.
David Newble has been appointed CEO of the Cambridge Cluster company, stepping up from his previous position as managing director.
He assumes responsibility for all SPT Labtech businesses including the recently acquired organisations.
Newble brings a wealth of industry expertise and has been instrumental in SPT Labtech’s transformation and growth since its acquisition by Battery Ventures in 2018.
Patrick Bennett, the former group CEO, will assume the role of chairman of the board and continue to work with David and the wider SPT Labtech team in executing the company’s ambitious commercial strategy.
Paul Ventura will lead global sales of SPT Labtech in the newly created role of VP of Sales. Drawing on his track record as director of sales, he will oversee and unify commercial operations across all the group’s brands and sales teams worldwide.
Joby Jenkins will take on overall responsibility for business development of all the SPT Labtech product brands. His role as VP of Business Development, also a newly created position, encompasses responsibility for product management and marketing.
Patrick Bennett said: “From a strong foundation of organic achievement and with several significant strategic acquisitions under our belt we are extremely well placed to create and deliver even more innovative solutions that enable our customers to do better research.
“These leadership appointments will enable us to further capitalise on our current position and advance our mission to transform laboratory workflows.”
SPT Labtech makes products that transform the way scientists work. For nearly two decades, its scientists, engineers and business innovators have created innovative solutions for liquid handling, sample preparation and management regarded as helping to accelerate research and making a real difference to human health.
Battery partners with exceptional founders and management teams developing category-defining businesses in markets including software and services, enterprise infrastructure, online marketplaces, healthcare IT and industrial technology.
It backs companies at all stages, ranging from seed and early to growth and buyout, and invests globally from six strategic locations – Boston, San Francisco and Menlo Park, California, Herzliya, Israel; London and New York.